THU-340 - Effectiveness of sofosbuvir and ledipasvir/sofosbuvir based regimens in hepatitis C virus genotype 3 infection: real-world data from Georgian hepatitis C elimination program

Autor: Tsertsvadze, T., Chkhartishvili, N., Abutidze, A., Sharvadze, L., Kerashvili, V., Kamkamidze, G., Zakalashvili, M., Skaggs, B., Gvinjilia, L., Shadaker, S., Nasrullah, M., Gamkrelidze, A., Kvaratskhelia, V., Zeuzem, S., Afdhal, N., Arora, S., Thornton, K., Averhoff, F.
Zdroj: In Journal of Hepatology April 2018 68 Supplement 1:S281-S282
Databáze: ScienceDirect